• Title/Summary/Keyword: Ovarian cysts

Search Result 80, Processing Time 0.03 seconds

High Rate of Gangrenous Adnexal Torsion: Dilemma of a Missing Silent Cancer

  • Sukkong, Kanchanok;Sananpanichkul, Panya;Teerakidpisan, Prasong;Bhamarapravatana, Kornkarn;Suwannarurk, Komsun
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.11
    • /
    • pp.4981-4984
    • /
    • 2016
  • Background: Adnexal torsion results in ischemia of structures distal to twisted pedicle and acute onset of pain is responsible for about 3% of all gynecologic emergencies. Ovarian torsion classically occurs in a pathological enlarged ovary, as with cancer, but diagnosis remains a challenge. Objective: Our purpose was to evaluate clinical risk factors predictive of torsion with gangrenous adnexa. Material and methods: A retrospective descriptive study and chart review of surgically proven ovarian torsion/adnexal torsion cases at the Obstetrics and Gynecology Department of Prapokklao Hospital, Chanthaburi, Thailand between January 2011 and December 2015 was conducted. Result: Seventy-eight cases were identified. Mean age at presentation was 35.5 years. The average maximum diameter of the ovarian tumors was 10.8 cm. The percentage of gangrenous ovarian cysts in this study was 46.2 (36/78). The precision to determine the pathological site by patient, physician and ultrasonography was 8.5, 24.2 and 83.3 percent, respectively with statistically significant variation. Conclusion: Ovarian/adnexal torsion remains a challenge condition especially in young nulliparous women. Sophisticated investigation does not guarantee ovary preservation. Combining clinical acumen, appropriate tests and detailed consideration may be the best practice at the present time.

Response of Ovaries and Cysts According to Treatment with GnRH or Combination of GnRH and $PGF_2{\alpha}$ in Dairy Cows with Follicular Cysts (난포낭종우에서 GnRH 또는 GnRH와$PGF_2{\alpha}$병용치료에 대한 난소 및 낭종의 반응)

  • Kang Hyun-gu;Kim Ill-hwa;Son Chang-ho
    • Journal of Veterinary Clinics
    • /
    • v.21 no.4
    • /
    • pp.384-394
    • /
    • 2004
  • This study was carried out to monitor the response of ovaries and cyst according to treatment with GnRH or combination of GnRH and $PGF_2{\alpha}$ in dairy cows with ovarian follicular cysts. Thirty cows were diagnosed as having follicular cysts by rectal palpation, ultrasonography and progesterone (P4) assays. Ten cows were treated with GnRH (control), and the other twenty were treated with $PGF_2{\alpha}$ at 10 days after GnRH treatment. All the animals were re-examined by ultrasonography and blood was collected for the measurement of plasma P4 concentration at day 0 (the day of treatment), day 7, day 10, day 13, day 24 and day 34, respectively. In 30 cows that were diagnosed with follicular cysts, mean plasma P 4 concentrations on day -II and day -I were 0.3 ng/ml and 0.4 ng/ml. On day 10 increased as 2.7$\pm$0.2 ng/ml. Mean cystic wall thickness by ultrasonography on day -11 and day -I were 2.1 mm and 2.2 mm. In 9 cows responded on luteinization of cystic wall, cystic wall thickness was 3.9$\pm$0.5 mm at day 10 after GnRH treatment. The responses of ovaries until day 10 after GnRH treatment included development of corpus luteum in the ovary bearing the cyst or in the contralateral ovary (12 cows), luteinization of cystic wall (6 cows) and clouding of the anechoic antrum of cysts (2 cows). The ovarian responses according to the combination of GnRH and $PGF_2{\alpha}$ included regression of the corpus luteum (12 cows), increase (1 cow) and no change (1 cow) of cyst size until last examination, and complete disappearance on day 13 (6 cows), 23 (6 cows) and 34 (4 cows). Combination treatment group of GnRH and $PGF_2{\alpha}$ showed a higher pregnancy rate within 100 days after initial treatment (40.0 vs 65.0%) and shorter intervals from the treatment to conception (45.4$\pm$25.8 vs 53.5$\pm$31.4 days) compared with control. It was concluded that the administration of $PGF_2{\alpha}$ following GnRH treatment is effective in shortening the interval from treatment to conception in cows with follicular cyst. Also, this study suggested that the response of the cyst according to treatment revealed various types. Therefore, veterinarians should pay attention to monitor of the response of cystic ovaries after treatment, specially no change, slowly decrease or increasement of cyst size after treatment.

Vaginal prolapse by ovarian follicular cysts in a female Jin-do dog

  • Kim, Bang-Sil;Kim, Hee-Su;Kim, Ki-Chul;Park, Chul-Ho;Oh, Ki-Seok;Son, Chang-Ho
    • Korean Journal of Veterinary Research
    • /
    • v.48 no.2
    • /
    • pp.223-225
    • /
    • 2008
  • A six-year-old, female Jin-do dog was referred for the recurrence of vaginal prolapse. Less than 7 months previously, the dog with the vaginal prolapse had been treated with hormone therapy because ultrasonography had identified a single follicular cyst in the left ovary. Three months after the first visit, the dog came into heat and the vaginal prolapse recurred. Ultrasonography showed multiple follicular cysts in both ovaries and radioimmunoassay detected a plasma estradiol-$17{\beta}$ concentration of 13.3 pg/ml. Treatment involved the repositioning of the vaginal prolapsed, ovariohysterectomy and the resection of the protruding tissue. The dog had been completely recovered two months later after the treatment.

Effects of Gonadotropin-Releasing Hormone on Reproductive Performance of Early Postpartum Dairy Cows and Cystic Cows (Gonadotropin-Releasing Hormone의 투여(投與)가 산욕기(産褥期)의 유우(乳牛)와 난소낭종유우(卵巢囊腫乳牛)의 번식효율(繁殖效率)에 미치는 영향(影響))

  • Hwang, Woo Suk
    • Korean Journal of Veterinary Research
    • /
    • v.21 no.1
    • /
    • pp.59-64
    • /
    • 1981
  • Holstein-Friesian cows(n=284) were given $100{\mu}g$ of gonadotropin-releasing hormone(GnRH) or saline solution by intramuscular injection at 10 to 22 days after parturition, and were investigated their reproductive performance and frequency of ovarian cysts. Among them 28 cystic cows were injected with $150{\mu}g$ of GnRH intramuscularly and examined the recovery rate. The results obtained in this study were summarized as follows: 1. The interval from calving to 1st ovulation was reduced from 28.2 days in controls to 16.5 days for cows given GnRH (p<0.01). 2. The intervals from calving to 1st estrus and from calving to conception were extended significantly in control group (p<0.05). 3. Inseminations per conception and conception rate at 1st insemination did not reveal difference between two groups. 4. Frequency of ovarian cysts was reduced from 14.0% in control to 4.20% for cows given GnRH (p<0.05). 5. Of the 28 cystic cows receiving $150{\mu}g$ of GnRH, 23(82.1%) responded to 1st treatment and returned to estrus $24.2{\pm}4.3$ days after treatment. 6. These data provide evidence for reduction in infertility and reproductive disorders in early postpartum dairy cows given GnRH as a prophylactic.

  • PDF

Progesterone assays as an aid for improving reproductive efficiency in dairy cattle II. Use of plasma or milk progesterone profiles for differential diagnosis of ovarian cysts (Progesterone 농도측정(濃度測定)에 의한 유우(乳牛)의 번식효율증진(繁殖效率增進)에 관한 연구(硏究) II. 혈액(血液) 및 유즙(乳汁)중 progesterone 농도측정(濃度測定)에 의한 난소낭종(卵巢囊腫)의 감별진단(鑑別診斷))

  • Kang, Byong-kyu;Choi, Han-sun;Choi, Sang-gong;Son, Chang-ho;Chon, Hong-suk
    • Korean Journal of Veterinary Research
    • /
    • v.34 no.1
    • /
    • pp.181-188
    • /
    • 1994
  • In 60 dairy cows with inactive ovaries, follicular cyst, luteal cyst, persistent corpus luteum and silent heat as diagnosed by rectal palpation, and those that had not resumed ovarian cycles until 60 days postpartum, progesterone concentrations for differential diagnosis of reproductive disorders were measured and were compared in matched plasma, skim milk and milk fat samples at 10 days interval. The incidence rate of reproductive disorders were as follows; inactive ovaries 20(33.3%), silent heat 11(18.3%), follicular cyst 7(11.7%), luteal cyst 7(11.7%), persistent corpus luteum 7(11.7%), pyometra 4(6.7%), vaginitis 2(3.3%), cystic corpus luteum 1(1.7%), and endometritis 1(1.7%), respectively. Cows having a progesterone concentration in plasma and skim milk < 1.0 ng/ml, and in milk fat < 80.0 ng/ml were considered to have inactive ovaries or follicular cyst. Those with concentrations in plasma and skim milk ${\geq}1.0ng/ml$, and in milk fat ${\geq}80.0ng/ml$ were regarded as the cases of luteal cyst or persistent corpus luteum. Progesterone concentrations in above cows did not differ significantly between the time of initial determination and the 10 days after initial determination. But progesterone concentrations in cows with silent heat did differ significantly between the time of initial determination and the 10 days after initial determination(P<0.05). The accuracy of rectal palpation for making a differential diagnosis of ovarian dysfunction, as defined on basis of progesterone concentrations, were as follows; follicular cyst 55.6%, luteal cyst 50.0%, inactive ovaries 90.5% and persistent corpus luteum 60.0%, respectively. It may be concluded that progesterone determinations at 10 days interval is practical as an aid to diagnosing ovarian dysfunction, particularly follicular cyst and luteal cyst.

  • PDF

Clinical and Endocrine Characteristics of Patients with McCune-Albright Syndrome (McCune-Albright 증후군의 임상적 및 내분비학적 특징)

  • Kwun, Yoojin;Kim, Yoo-Mi;Kim, Ja-Hye;Choi, Jin-Ho;Yoo, Han-Wook
    • Journal of The Korean Society of Inherited Metabolic disease
    • /
    • v.13 no.2
    • /
    • pp.120-125
    • /
    • 2013
  • Purpose: McCune-Albright syndrome (MAS) is caused by activating mutations in the GNAS gene, resulting in peripheral precocious puberty, caf$\acute{e}$-au-lait spots, and polyostotic fibrous dysplasia (POFD). The aim of the present study was to describe the diverse clinical and endocrine characteristics of patients with MAS. Methods: Seven patients with MAS were included in this study and medical charts were reviewed retrospectively for following parameters: patient's sex and age at diagnosis, POFD, ovarian cysts, and precocious puberty. Results: The mean age at diagnosis was $5.8{\pm}4.2$ years. One patient was male (14%) and the other six patients were female (86%). Peripheral precocious puberty was associated with 6 patients (86%). Five patients manifested premature menarche as early as 2 to 5 years of age. Letrozole was administered to 4 patients, tamoxifen to one patient and GnRH agonist to one patient. Five females developed ovarian cysts. Thyroid function tests were performed in all patients and one patient showed hyperthyroidism (14%) and has been treated with methimazole. One patient presented with pseudohypoparathyroisdism, phosphaturia, calciuria suggesting hypophosphatemic rickets. Six patients (86%) revealed POFD. One patient had symptoms of optic nerve compression and secondary esotropia and 2 patients had bone pain. Conclusion: This study described clinical characteristics and endocrine complications of patients with MAS. Careful physical examinations with history taking and serial endocrine function tests should be needed to detect complications such as endocrinologic hyperfunction and POFD.

  • PDF

Therapeutic Effect of Prostaglandin $F_{2a}$ on Cows with Ovarian Disease (Prostaglandin $F_{2a}$에 의한 유우난소질환의 치료효과)

  • Kang Byong-Kyu;Choi Sang-Gong
    • Journal of Veterinary Clinics
    • /
    • v.3 no.2
    • /
    • pp.317-324
    • /
    • 1986
  • A total of 600 Holstein cows in Chonnam province were examined to make a diagnosis on the ovarian diseases. By clinical signs and rectal examinations, 120 cows were founded to have ovarian diseases such as 40 cows with suboestrus, 40 cows with persistent corpus luteum, 40 cows with luteal cysts. The Prostaglandin $F_{2{\alpha}}$ (PG $F_{2{\alpha}}$) was administered intramuscularly and intradermic vaginally ; also intraovarian injections and intrauterine infusions was made. Comparisons were made on the effect of PG $F_{2{\alpha}}$ on the ovarian diseases. The results obtained were summarized as follows. 1. Induction of normal estrum after PG $F_{2{\alpha}}$ treatment was 75.0~82.5%(mean 78.3%). The conception rate was 83.3~84.8% (mean 84.0%) and average services per conception was 1.6~l.8(mean 1.7). Days from treatment to estrum was 3.9~4.3(mean 4.1) days. 2. Average conception rate was different according to the routes of administration: intraovary 91.7%, intra-uterus 88.0%, intramuscle 80.9% and intradermic vagina 75.0%, respectively.

  • PDF

Aquaporin 4 expression is downregulated in large bovine ovarian follicles

  • Kim, Chang-Woon;Choi, Eun-Ju;Kim, Eun-Jin;Siregar, Adrian S.;Han, Jaehee;Kang, Dawon
    • Journal of Animal Reproduction and Biotechnology
    • /
    • v.35 no.4
    • /
    • pp.315-322
    • /
    • 2020
  • Aquaporin channels (AQPs) are known to play an important role in the development of ovarian follicles through their function in water transport pathways. Compared to other AQPs, research on the role of AQP4 in female reproductive physiology, particularly in cattle, remains limited. In our previous study, gene chip microarray data showed a downregulation of AQP4 in bovine cystic follicles. This study was performed to validate the AQP4 expression level at the protein level in bovine follicles using immunohistochemistry, Western blotting, and immunoprecipitation assays. Immunostaining data showed that AQP4 was expressed in granulosa and theca cells of bovine ovarian follicles. The ovarian follicles were classified according to size as small (< 10 mm) or large (> 25 mm) in diameter. Consistent with earlier microarray data, semi-quantitative PCR data showed a decrease in AQP4 mRNA expression in large follicles. Western blot analysis showed a downregulation of the AQP4 protein in large follicles. In addition, AQP4 was immunoprecipitated and blotted with anti-AQP4 antibody in small and large follicles. Accordingly, AQP4 exhibited a low expression in large follicles. These results show that AQP4 is downregulated in bovine ovarian large follicles, suggesting that the downregulation of AQP4 expression may interfere with follicular water transport, leading to bovine follicular cysts.

Histopathological observation on the uterus and ovary of rats and mice treated with Ivermectin (Ivermectin을 투여한 rat와 mouse의 자궁 및 난소에 대한 병리조직학적 관찰)

  • Cho, Yoo-joung;Lee, Cha-soo
    • Korean Journal of Veterinary Research
    • /
    • v.36 no.2
    • /
    • pp.429-440
    • /
    • 1996
  • In order to know morphological changes on the female genital organs by Ivermectin(IVM) administration, the histopathological observation was carried out in the organs of rat and mouse treated with the overdose of IVM. In the microscopical findings of the uterus, there were many mitotic figures, epithelial hyperplasia and papillary foldings in the endometrial surface. The increased prevalance of uterine glands, uterine epithelia and glands hyperplasia were markedly presented on diverse patterns adenoma-like structure and single nodular or multiple polyp-like adenoma. In ovary, primary and mature follicles were decreased in number, and hypoplasia of ovarian follicles, atretic follicles, follicular cysts and ovarian atropy were observed. It was considered that IVM administration resulted in follicular hypoplasia and atropy of ovary, and hyperplasia of uterine gland and endometrial surface epithelium might be transformed to neoplasia of glandular structures.

  • PDF

A Study on Clinical Response to Controlled Ovarian Hyperstimulation of In Vitro Fertilization and Embryo Transfer According to the Size of Baseline Ovarian Cyst (체외수정시술을 위한 과배란유도시 난소낭종의 크기에 따른 임상적 반응에 대한 연구)

  • Lee, Yong-Soek;Jung, Byeong-Jun;Lee, Sang-Hoon;Hur, Min
    • Clinical and Experimental Reproductive Medicine
    • /
    • v.26 no.3
    • /
    • pp.355-362
    • /
    • 1999
  • Objective: This study was performed to compare the clinical response to controlled ovarian hyperstimulation (COH) of in vitro fertilization and embryo transfer (IVF-ET) according to the size of baseline ovarian cyst. Method: From February 1992 to March 1999, a retrospective analysis was done of 272 cases who underwent COH using mid-luteal phase long protocol of gonadotropin-releasing hormone agonist (GnRH-a) for IVF-ET. These cases were divided into four group; group 1 (n=63) had cysts with mean diameters between 20.0 and 29.0 mm on their baseline ultrasound on cycle day 3, group 2 (n=57, $30.0{\sim}49.0mm$), group 3 (n=68, >50.0 mm) and control group (n=84). Cases were excluded according to the following criteria; pure male factor infertility, the presence of only one ovary, high CA-125 level and previous endometriosis. Results: There were no statistically significant differences between cases with baseline ovarian cyst <50.0 mm in diameter and control group in any of the parameters. However, cases with baseline ovarian cyst>50.0 mm in mean diameter needed more amount of human menopausal gonadotropin (hMG), showed significantly lower estradiol ($E_2$) level, the number of follicle >15.0 mm on the day of human chorionic gonadotropin (hCG) administration, the number of oocytes retrieved, the number of mature oocytes, and pregnancy rate compared with control group. Conclusion: This study suggests that cases with baseline ovarian cyst <50.0 mm in diameter do not adversely impact on IVF-ET outcome. However, cases with baseline ovarian cyst >50.0 mm in diameter had adverse effects on various parameters. Therefore, to improve the outcome of IVF-ET in these cases, ovarian cyst aspiration prior to initiating COH may be required.

  • PDF